Sunny Sanyal - Varian Medical Sr. VP and President of Imaging Components Bus.es

President

Mr. Sunny Sanyal is no longer Senior Vice President of the Company and President Imaging Components Businesses of Varian Medical Systems, Inc., with effect from January28, 2017. He was appointed Senior Vice President and President, Imaging Components Business in February 2014. From August 2010 to January 2014, Mr. Sanyal served as the Chief Executive Officer of TSystem Inc. . Mr. Sanyal worked for McKesson Corporation as the Chief Operating Officer of McKesson Provider Technologies from December 2006 to July 2010 and as the Group President of McKessons Clinical Information Systems division from April 2004 to December 2006. Previously, he held various management positions with GE Healthcare, Accenture and IDX Systems Corporation since 2014.
Age 50
Tenure 10 years
Professional MarksMBA
Phone650 493-4000
Webwww.varian.com
Sanyal holds an M.B.A. degree from Harvard Business School, an M.S. degree in industrial engineering from Louisiana State University, and a B.E. degree in electrical engineering from the University of Bombay.

Varian Medical Management Efficiency

The company has Return on Asset of 5.92 % which means that on every $100 spent on assets, it made $5.92 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.51 %, implying that it generated $13.51 on every 100 dollars invested. Varian Medical's management efficiency ratios could be used to measure how well Varian Medical manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 350.5 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Varian Medical Systems has a current ratio of 1.48, which is typical for the industry and considered as normal. Debt can assist Varian Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Varian Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Varian Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Varian to invest in growth at high rates of return. When we think about Varian Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

William PayneAir Transport Services
53
Brian DickmanGetty Realty
48
Patrick GuidoAsbury Automotive Group
47
George KarolisAsbury Automotive Group
42
Jed MilsteinAsbury Automotive Group
55
John HartmanAsbury Automotive Group
55
Robert JordanSouthwest Airlines
63
William StaxAsbury Automotive Group
48
Richard CorradoAir Transport Services
64
Michael WelchAsbury Automotive Group
49
Kathleen WaytonSouthwest Airlines
N/A
Mark ShawSouthwest Airlines
61
Mark OlearGetty Realty
60
Jeff LambSouthwest Airlines
53
Stan AlexanderSouthwest Airlines
N/A
James OGradyAir Transport Services
N/A
Sean GoodmanAsbury Automotive Group
53
Michael VenSouthwest Airlines
62
Holger BlankensteinVolaris
49
Reid GrandleSouthwest Airlines
N/A
Danion FieldingGetty Realty
47
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company was founded in 1948 and is headquartered in Palo Alto, California. Varian Medical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people. Varian Medical Systems (VAR) is traded on New York Stock Exchange in USA and employs 10,000 people.

Management Performance

Varian Medical Systems Leadership Team

Elected by the shareholders, the Varian Medical's board of directors comprises two types of representatives: Varian Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varian. The board's role is to monitor Varian Medical's management team and ensure that shareholders' interests are well served. Varian Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varian Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Laret, Independent Director
Regina Dugan, Independent Director
Jose Baselga, Director
Erich Reinhardt, Independent Director
Timothy Guertin, Independent Vice Chairman of the board
Kolleen Kennedy, Executive Vice President, President - Proton Solutions Division and Chief Growth Officer
J Bruff, Chief Financial Officer, Senior Vice President - Finance
Anat Ashkenazi, Independent Director
Susan Bostrom, Independent Director
JeanLuc Butel, Independent Director
Kevin OReilly, Senior Vice President and President Oncology Systems
Sunny Sanyal, Sr. VP and President of Imaging Components Bus.es
Dow Wilson, President, Chief Executive Officer, Director
Francis Facchini, President Interventional Solutions Business
Clarence Verhoef, Senior Vice President - Finance, Corporate Controller
Jeffrey Balser, Independent Director
R Eckert, Independent Chairman of the Board
Venkatraman Thyagarajan, Independent Director
Anshul Maheshwari, Vice President Treasurer, IR Contact Officer
David Illingworth, Independent Director
Judy Bruner, Independent Director
Gary Bischoping, Chief Financial Officer, Senior Vice President - Finance
Juarez Monroeas, Senior Vice President - Human Resources and Chief People Officer
Elisha Finney, CFO and Executive VP of Fin.
John Kuo, Senior Vice President, General Counsel, Corporate Secretary
Rafael Torres, Senior Vice President - Business Development and Strategy
Christopher Toth, President, Chief Executive Officer, Chief Operating Officer
Mike Bruff, Vice president, IR Contact Officer
Michael Hutchinson, Senior Vice President, Chief Legal Officer, Corporate Secretary
Andrew Eckert, Independent Chairman of the Board
Phillip Febbo, Chief Medical Officer, Director
Spencer Sias, Vice President - Corporate Communications and Investor Relations
Chris Toth, President - Varian Oncology Systems
Ruediger NaumannEtienne, Independent Director
Michelle Beau, Independent Director

Varian Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varian Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Varian Medical Systems information on this page should be used as a complementary analysis to other Varian Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Consideration for investing in Varian Stock

If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio